StockGlow

BioMarin Pharmaceutical Inc. (BM8.F)

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

53.70-0.01%Healthcare
Compare BM8.F with
StockGlow Score
89
Bullish
BearishBullish
1 year ago+7.5%

The outlook

BioMarin Pharmaceutical Inc. currently reads as bullish based on above its 50- & 200-day averages, 85% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range85% of the way from its 52-week low to high
Market cap
$10.38B
52-wk high
55.66
52-wk low
42.62
50-day avg
49.58
200-day avg
48.32
Trailing P/E
44.0

Similar stocks

ICY.FIncyte Corporation$110.35-4.38%TE1.FBio-Techne Corporation$62.52+0.58%DUL.FAlnylam Pharmaceuticals, Inc.$178.20-28.66%VX1.FVertex Pharmaceuticals Incorporated$411.25-4.09%AB3A.FSarepta Therapeutics, Inc.$13.50+1.50%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy